Featured Research

from universities, journals, and other organizations

MRI: Non-invasive diagnostic tool for diagnosing testicular cancer

Date:
March 2, 2010
Source:
American College of Radiology / American Roentgen Ray Society
Summary:
Researchers have found that non-invasive magnetic resonance imaging (MRI) is a good diagnostic tool for the evaluation and staging of testicular cancer and may improve patient care by sparing some men unnecessary surgery.

Researchers have found that non-invasive magnetic resonance imaging (MRI) is a good diagnostic tool for the evaluation and staging of testicular cancer and may improve patient care by sparing some men unnecessary surgery, according to a study in the March issue of the American Journal of Roentgenology.

"Medical imaging plays an important role in the investigation of testicular masses," said Athina C. Tsili, MD, lead author of the study. "Sonography, although the primary imaging technique for the evaluation of scrotal contents, does not always allow confident characterization of the nature of a testicular mass. The purpose of our study was to assess the role of MRI in the preoperative characterization and local staging of testicular masses," said Tsili.

Prior surgery and histological examination revealed 28 malignant and 8 benign lesions in 33 patients. "Of those 36 lesions, MRI correctly identified all 28 malignant lesions and 7/8 benign lesions," she said.

"A possible diagnosis of benign lesion based on MRI features may improve patient care and decrease the number of unnecessary surgical procedures," said Tsili.

"MRI is an efficient diagnostic tool for the evaluation of testicular masses. It is accurate in the preoperative differentiation of benign and malignant masses, facilitating accurate estimation of the local extent of disease in patients with malignant tumors," she said.


Story Source:

The above story is based on materials provided by American College of Radiology / American Roentgen Ray Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. Tsili et al. MRI in the Characterization and Local Staging of Testicular Neoplasms. American Journal of Roentgenology, 2010; 194 (3): 682 DOI: 10.2214/AJR.09.3256

Cite This Page:

American College of Radiology / American Roentgen Ray Society. "MRI: Non-invasive diagnostic tool for diagnosing testicular cancer." ScienceDaily. ScienceDaily, 2 March 2010. <www.sciencedaily.com/releases/2010/02/100222121626.htm>.
American College of Radiology / American Roentgen Ray Society. (2010, March 2). MRI: Non-invasive diagnostic tool for diagnosing testicular cancer. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2010/02/100222121626.htm
American College of Radiology / American Roentgen Ray Society. "MRI: Non-invasive diagnostic tool for diagnosing testicular cancer." ScienceDaily. www.sciencedaily.com/releases/2010/02/100222121626.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins